Career records & work history
Lawyers & Attorneys
Michael James Tennant - Lawyer
Licenses:
Montana - Active 2008
Michael D Tennant, 55151 Quarry Rd, Troy, NH 03465
Michael Tennant Phones & Addresses
151 Quarry Rd, Troy, NH 03465
Saint Louis, MO
Kirkland, WA
Seattle, WA
Binghamton, NY
Berkshire, NY
Johnson City, NY
High Springs, FL
Coal City, WV
1552 NW 51St St APT 303, Seattle, WA 98107 206-3728350
Work
Position:
Service Occupations
Education
Degree:
High school graduate or higher
Ranks
Licence:
Montana - Active
Date:
2008
Emails
Mentions for Michael D Tennant
Michael Tennant resumes & CV records
Resumes
Senior Scientist Cell Banking
Location:
Andover, MA
Industry:
Pharmaceuticals
Work:
Pfizer
Senior Scientist Cell Banking Mds Pharma Services Mar 2004 - Nov 2006
Supervisor - Cell Bank Production and Testing Targeted Genetics Jan 2002 - Dec 2003
Scientist - Upstream Process Development Uf Gene Therapy Vector Core 1998 - Dec 2001
Biological Scientist
Senior Scientist Cell Banking Mds Pharma Services Mar 2004 - Nov 2006
Supervisor - Cell Bank Production and Testing Targeted Genetics Jan 2002 - Dec 2003
Scientist - Upstream Process Development Uf Gene Therapy Vector Core 1998 - Dec 2001
Biological Scientist
Education:
Northeastern University 2018 - 2020
Masters Binghamton University 1988 - 1996
Bachelors, Bachelor of Science
Masters Binghamton University 1988 - 1996
Bachelors, Bachelor of Science
Skills:
Pharmaceutical Industry, Biotechnology, Drug Discovery, Gmp, Glp, Life Sciences, Cell, Biopharmaceuticals, Technology Transfer, Sop, Validation, Lifesciences, Hplc, Drug Development, Chromatography
Michael Tennant
Michael Tennant
Location:
United States
Michael Tennant
Location:
United States
Publications & IP owners
Us Patents
Adiponectin Gene Therapy
US Patent:
2003014, Aug 7, 2003
Filed:
Jan 13, 2003
Appl. No.:
10/341972
Inventors:
Sergei Zolotukhin - Gainesville FL, US
Michael Tennant - Seattle WA, US
Michael Tennant - Seattle WA, US
International Classification:
A61K048/00
C12N007/00
C12N015/861
C12N007/00
C12N015/861
US Classification:
424/093200, 435/456000, 435/235100
Abstract:
Adiponectin cDNA was cloned into AAV serotypes 1, 2, and 5-based expression vectors. Virions containing these vectors were administered to the livers of rat subjects via portal vein injection. A single injection of 6×10virions of the vector caused a sustained and statistically significant reduction in body weight of the treated animals compared to the control animals. This occurred in the absence of side effects. Compared to control animals, the subject rats also exhibited reduced adipose tissue mass, reduced appetite, improved insulin sensitivity, and improved glucose tolerance.
Adiponectin Gene Therapy
US Patent:
2006023, Oct 26, 2006
Filed:
Nov 22, 2005
Appl. No.:
11/285689
Inventors:
Sergei Zolotukhin - Gainesville FL, US
Michael Tennant - Seattle WA, US
Michael Tennant - Seattle WA, US
International Classification:
A61K 48/00
C12N 15/861
C12N 15/861
US Classification:
424093200, 514044000, 435456000
Abstract:
Adiponectin cDNA was cloned into AAV serotypes 1, 2, and 5-based expression vectors. Virions containing these vectors were administered to the livers of rat subjects via portal vein injection. A single injection of 6×10virions of the vector caused a sustained and statistically significant reduction in body weight of the treated animals compared to the control animals. This occurred in the absence of side effects. Compared to control animals, the subject rats also exhibited reduced adipose tissue mass, reduced appetite, improved insulin sensitivity, and improved glucose tolerance.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.